SLUS:XETRA:XETRA-iShares MSCI USA ESG Screened UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 10.23

Change

+0.03 (+0.25)%

Market Cap

USD 0.32B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.48 (+0.95%)

USD 420.85B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.16 (+0.96%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.82%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.27 (+0.96%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.29 (+1.18%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.35 (+0.78%)

USD 102.32B
8R80:XETRA Amundi Index Solutions - Amund..

+1.10 (+0.77%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.53 (+1.07%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.08 (+0.08%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.16 (+0.20%)

USD 80.38B

ETFs Containing SLUS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.78% 90% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.78% 90% A- 89% A-
Trailing 12 Months  
Capital Gain 39.39% 88% B+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.39% 88% B+ 87% B+
Trailing 5 Years  
Capital Gain 106.73% 96% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 106.73% 96% N/A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 15.93% 88% B+ 85% B
Dividend Return 15.93% 88% B+ 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.88% 31% F 44% F
Risk Adjusted Return 100.28% 94% A 95% A
Market Capitalization 0.32B 55% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.